Innovus Pharmaceuticals

Innovus Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 13, 2019

Innovus Pharmaceuticals Announces that its Delta Prime Savings Club E-Commerce Marketplace is on Track for Annual Sales of Approximately $3 million in 2019

Cannabis and OTC Medications Sector Snapshot: More Health Canada Approval with Rise of Cannabis / Wellness Market

Innovus Pharmaceuticals Announces Progress in Fulfilling the Regulatory and Manufacturing Steps to Receive Market Authorization for FlutiCare in Canada

Muscle and Repair Treatments versus Surgery - Europe and Global Markets offer Big Opportunities

Biotech / Pharma Stock Snapshot- The Pain Gain: More OTC Pain Alternatives see Continued Growth

The Pain Gain: More OTC Pain Alternatives see Continued Growth

Innovus Pharmaceuticals Receives Notification to Market and Sell CarvaNum for Muscle Recovery in the European Union

Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare (a Competitor of Prilosec OTC)

Innovus Pharma Releases Results from Annual Shareholders Meeting